Annual CFO
$3.68 M
+$29.91 M+114.01%
December 31, 2023
Summary
- As of February 7, 2025, TCON annual cash flow from operations is $3.68 million, with the most recent change of +$29.91 million (+114.01%) on December 31, 2023.
- During the last 3 years, TCON annual CFO has risen by +$20.72 million (+121.57%).
- TCON annual CFO is now at all-time high.
Performance
TCON Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.77 M
-$226.00 K-8.89%
June 30, 2024
Summary
- As of February 7, 2025, TCON quarterly cash flow from operations is -$2.77 million, with the most recent change of -$226.00 thousand (-8.89%) on June 30, 2024.
- Over the past year, TCON quarterly CFO has dropped by -$2.25 million (-430.46%).
- TCON quarterly CFO is now -118.40% below its all-time high of $15.05 million, reached on September 30, 2023.
Performance
TCON Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$9.22 M
+$3.08 M+50.23%
June 30, 2024
Summary
- As of February 7, 2025, TCON TTM cash flow from operations is $9.22 million, with the most recent change of +$3.08 million (+50.23%) on June 30, 2024.
- Over the past year, TCON TTM CFO has increased by +$5.54 million (+150.76%).
- TCON TTM CFO is now at all-time high.
Performance
TCON TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TCON Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +114.0% | -430.5% | +150.8% |
| 3 y3 years | +121.6% | +65.5% | +132.6% |
| 5 y5 years | +111.9% | +52.0% | +139.0% |
TCON Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +114.0% | -118.4% | +65.5% | at high | +132.6% |
| 5 y | 5-year | at high | +114.0% | -118.4% | +67.1% | at high | +132.6% |
| alltime | all time | at high | +111.9% | -118.4% | +72.8% | at high | +129.2% |
TRACON Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$2.77 M(+8.9%) | $9.22 M(+50.2%) |
| Mar 2024 | - | -$2.54 M(+387.2%) | $6.14 M(+66.9%) |
| Dec 2023 | $3.68 M(-114.0%) | -$522.00 K(-103.5%) | $3.68 M(-907.9%) |
| Sep 2023 | - | $15.05 M(-357.3%) | -$455.00 K(-98.0%) |
| Jun 2023 | - | -$5.85 M(+16.9%) | -$22.33 M(-8.8%) |
| Mar 2023 | - | -$5.00 M(+7.5%) | -$24.50 M(-6.6%) |
| Dec 2022 | -$26.24 M(+16.3%) | -$4.65 M(-31.8%) | -$26.24 M(-1.7%) |
| Sep 2022 | - | -$6.83 M(-14.8%) | -$26.70 M(-5.6%) |
| Jun 2022 | - | -$8.02 M(+18.9%) | -$28.30 M(+15.7%) |
| Mar 2022 | - | -$6.74 M(+31.8%) | -$24.45 M(+8.3%) |
| Dec 2021 | -$22.57 M(+32.4%) | -$5.11 M(-39.3%) | -$22.57 M(+7.1%) |
| Sep 2021 | - | -$8.42 M(+101.8%) | -$21.08 M(+24.5%) |
| Jun 2021 | - | -$4.17 M(-14.1%) | -$16.93 M(+1.9%) |
| Mar 2021 | - | -$4.86 M(+34.0%) | -$16.61 M(-2.5%) |
| Dec 2020 | -$17.04 M(-27.9%) | -$3.63 M(-15.1%) | -$17.04 M(-3.5%) |
| Sep 2020 | - | -$4.27 M(+10.7%) | -$17.66 M(-11.6%) |
| Jun 2020 | - | -$3.85 M(-27.2%) | -$19.97 M(-8.8%) |
| Mar 2020 | - | -$5.29 M(+24.7%) | -$21.89 M(-7.4%) |
| Dec 2019 | -$23.65 M(-23.2%) | -$4.24 M(-35.5%) | -$23.65 M(-14.1%) |
| Sep 2019 | - | -$6.58 M(+14.0%) | -$27.53 M(+1.3%) |
| Jun 2019 | - | -$5.77 M(-18.1%) | -$27.18 M(-13.9%) |
| Mar 2019 | - | -$7.05 M(-13.2%) | -$31.58 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$30.78 M(+132.4%) | -$8.13 M(+30.5%) | -$30.78 M(+23.3%) |
| Sep 2018 | - | -$6.22 M(-38.8%) | -$24.97 M(+43.5%) |
| Jun 2018 | - | -$10.18 M(+62.7%) | -$17.40 M(+45.8%) |
| Mar 2018 | - | -$6.25 M(+170.9%) | -$11.93 M(-9.9%) |
| Dec 2017 | -$13.24 M(-51.2%) | -$2.31 M(-272.4%) | -$13.24 M(-21.7%) |
| Sep 2017 | - | $1.34 M(-128.4%) | -$16.92 M(-27.4%) |
| Jun 2017 | - | -$4.71 M(-37.8%) | -$23.30 M(-16.9%) |
| Mar 2017 | - | -$7.57 M(+26.4%) | -$28.05 M(+3.3%) |
| Dec 2016 | -$27.15 M(+41.7%) | -$5.99 M(+18.7%) | -$27.15 M(-5.3%) |
| Sep 2016 | - | -$5.04 M(-46.7%) | -$28.68 M(+5.6%) |
| Jun 2016 | - | -$9.45 M(+41.8%) | -$27.17 M(+29.2%) |
| Mar 2016 | - | -$6.67 M(-11.3%) | -$21.03 M(+9.7%) |
| Dec 2015 | -$19.16 M(-1190.0%) | -$7.52 M(+112.8%) | -$19.16 M(+29.4%) |
| Sep 2015 | - | -$3.53 M(+6.7%) | -$14.81 M(+15.5%) |
| Jun 2015 | - | -$3.31 M(-31.0%) | -$12.82 M(+15.3%) |
| Mar 2015 | - | -$4.80 M(+51.6%) | -$11.12 M(-732.6%) |
| Dec 2014 | $1.76 M(-126.4%) | -$3.17 M(+105.1%) | $1.76 M(-64.3%) |
| Sep 2014 | - | -$1.54 M(-4.1%) | $4.92 M(-23.9%) |
| Jun 2014 | - | -$1.61 M(-119.9%) | $6.47 M(-19.9%) |
| Mar 2014 | - | $8.08 M | $8.08 M |
| Dec 2013 | -$6.67 M(+22.8%) | - | - |
| Dec 2012 | -$5.43 M | - | - |
FAQ
- What is TRACON Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual CFO year-on-year change?
- What is TRACON Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly CFO year-on-year change?
- What is TRACON Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals TTM CFO year-on-year change?
What is TRACON Pharmaceuticals annual cash flow from operations?
The current annual CFO of TCON is $3.68 M
What is the all time high annual CFO for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual cash flow from operations is $3.68 M
What is TRACON Pharmaceuticals annual CFO year-on-year change?
Over the past year, TCON annual cash flow from operations has changed by +$29.91 M (+114.01%)
What is TRACON Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of TCON is -$2.77 M
What is the all time high quarterly CFO for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly cash flow from operations is $15.05 M
What is TRACON Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, TCON quarterly cash flow from operations has changed by -$2.25 M (-430.46%)
What is TRACON Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of TCON is $9.22 M
What is the all time high TTM CFO for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high TTM cash flow from operations is $9.22 M
What is TRACON Pharmaceuticals TTM CFO year-on-year change?
Over the past year, TCON TTM cash flow from operations has changed by +$5.54 M (+150.76%)